posted on 2022-02-08, 10:37authored byRV Chudasama, K Khunti, WC Ekezie, M Pareek, F Zaccardi, CL Gillies, S Seidu, MJ Davies, YV Chudasama
<div>Background and aims</div><div>Vaccine hesitancy is an ongoing major challenge. We aimed to assess the uptake and hesitancy of the COVID-19 vaccination.</div><div><br></div><div>Methods</div><div>A short online survey was posted between April 12 to July 31, 2021 targeted at health and social care workers (HCWs) across the globe.</div><div><br></div><div>Results</div><div>275 from 37 countries responded. Most were hospital or primary care physicians or nurses, 59% women, aged 18–60 years, and 21% had chronic conditions with most prevalent being diabetes, hypertension, and asthma. We found that most HCWs (93%) had taken or willing to receive the COVID-19 vaccine. While 7% were vaccine hesitant (mainly women aged 30–39 years), respondents main concerns was the safety or potential side effects. Vaccine willing respondents raised concerns of unequal access to the COVID-19 vaccination in some countries, and highlighted that the only solution to overcoming COVID-19 infections was the vaccine booster doses given annually and free mass vaccination.</div><div><br></div><div>Conclusions</div><div>This study found that the majority of the frontline HCWs are willing to receive the COVID-19 vaccine. Further promotion of the COVID-19 vaccine would reassure and persuade HCWs to become vaccinated.</div>
Funding
We acknowledge the support from the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM), and the NIHR Leicester Biomedical Research Centre.
History
Citation
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Volume 16, Issue 1, January 2022, 102361
Author affiliation
Department of Respiratory Sciences, University of Leicester
Version
AM (Accepted Manuscript)
Published in
Diabetes and Metabolic Syndrome: Clinical Research and Reviews